{
    "2020-06-29": [
        [
            {
                "time": "2020-06-29",
                "original_text": "恒瑞医药：钧鸣生命科学多策略私募证券投资基金已完成备案",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "私募基金",
                        "备案"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-06-29",
                "original_text": "上半年十大牛股排名出炉 大涨前谁推荐了？",
                "features": {
                    "keywords": [
                        "牛股",
                        "排名",
                        "推荐"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-29",
                "original_text": "投资人视角丨国家联采办“拍了拍”各大药企，第三批药品集采工作蓄势待发！",
                "features": {
                    "keywords": [
                        "国家联采办",
                        "药品集采",
                        "药企"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-06-29",
                "original_text": "资金流向复盘｜北水买入腾讯，卖出美团点评、中芯国际",
                "features": {
                    "keywords": [
                        "北水",
                        "腾讯",
                        "美团",
                        "中芯国际"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "互联网"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2020-06-29",
                "original_text": "海正药业：盐酸伊立替康注射液注册申请主动撤回并获得批准",
                "features": {
                    "keywords": [
                        "海正药业",
                        "盐酸伊立替康",
                        "撤回",
                        "批准"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-06-29",
                "original_text": "国产 PD-1 正迎来密集收获期，这些药企被看好",
                "features": {
                    "keywords": [
                        "PD-1",
                        "药企",
                        "收获期"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-29",
                "original_text": "Wind快讯 | 每日医药行业动态（2020-6-29）",
                "features": {
                    "keywords": [
                        "医药",
                        "行业动态"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-06-29",
                "original_text": "恒瑞医药：多名高管合计减持0.0033%股份 减持股份",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "高管",
                        "减持"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-06-29",
                "original_text": "恒瑞医药：董监高孙辉、刘疆、孙绪根减持17万股 陶维康未减持 减持计划已完成",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "董监高",
                        "减持"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-06-29",
                "original_text": "701亿资金争夺20股：主力资金重点出击4股(名单)",
                "features": {
                    "keywords": [
                        "资金",
                        "主力",
                        "出击"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}